Roth Capital lowered the firm’s price target on Cinemark (CNK) to $34 from $36 but keeps a Buy rating on the shares after its Q2 results. The firm continues to view Cinemark as an attractive, defensive asset that is positioned within the 2 year window of positive content cycle, and while a softer Q3 is expected, there is growing optimism around a strong Q4 rebound leading into 2026, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark Holdings: Strong Performance and Promising Future with Buy Rating
- Cinemark price target lowered to $33 from $36 at Wells Fargo
- Positive Outlook for Cinemark Holdings: Anticipated Growth in EBITDA and Free Cash Flow
- Cinemark Reports Strong Q2 2025 Financial Results
- Cinemark’s Earnings Call: Record Growth Amid Challenges